FUJIFILM Diosynth Biotechnologies is a contract development and manufacturing organization (CDMO) that helps partners develop and produce biologics, including vaccines and gene therapies. Its core technical expertise covers lipid nanoparticles, liposomes, mRNA synthesis, and advanced GMP manufacturing technologies. The company is part of the broader FUJIFILM global technology group, which operates across healthcare, electronics, business innovation, and imaging.
The organisation maintains a global presence with sites in Denmark, the United States, and other locations worldwide. It is backed by the resources of its parent company, which employs over 70,000 people globally. The company's operational scope within the group also includes work in regenerative medicine, diagnostic and endoscopic imaging, medical systems, and life sciences.
FUJIFILM Diosynth Biotechnologies states a commitment to sustainability, with initiatives including powering its sites with 100% renewable energy. The broader FUJIFILM group's corporate philosophy centres on delivering 'Value from Innovation' across its diverse business segments.
